Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users

Marc Gourevitch, Peter A. Selwyn, Katherine Davenny, Donna Buono, Ellie E. Schoenbaum, Robert S. Klein, Gerald H. Friedland

Research output: Contribution to journalArticle

Abstract

Objective: To describe the effects of human immunodeficiency virus (HIV) infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Design: Cohort study of intravenous drug users. Setting: Medical clinic in a hospital-based methadone maintenance treatment program in New York City. Patients: Fifty patients with syphilis, of whom 31 were HIV seropositive and 19 HIV seronegative. Measurements: Serologic tests for syphilis and clinical manifestations. Results: Stage of syphilis at presentation was not associated with HIV serologic status. No unusual or fulminant manifestations of early syphilis or neurosyphilis were noted among HIV-seropositive cases. Maximum nontreponemal titers were higher among HIV-seropositive (median, 1:128) than among HIV-seronegative (median, 1:32) patients with syphilis (P = 0.05); this difference was present only among patients with first-episode syphilis. All 26 evaluable, HIV-seropositive patients treated for syphilis responded appropriately, including 13 patients given standard or less-than-standard doses of penicillin. Seven of 43 patients (16%) showed reversion to negative treponemal antibody assay results after treatment for syphilis; this finding was not associated with HIV infection, CD4 count, or stage of syphilis. Low nontreponemal titer was weakly associated with treponemal test reversion. Conclusions: Infection with HIV did not alter the stage at presentation, clinical course, serologic manifestations, or response to treatment of syphilis in this cohort of intravenous drug users.

Original languageEnglish (US)
Pages (from-to)350-355
Number of pages6
JournalAnnals of Internal Medicine
Volume118
Issue number5
StatePublished - Mar 1 1993

Fingerprint

Virus Diseases
Syphilis
Drug Users
HIV
Therapeutics
Neurosyphilis
Methadone
Serologic Tests
CD4 Lymphocyte Count
Penicillins
Cohort Studies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gourevitch, M., Selwyn, P. A., Davenny, K., Buono, D., Schoenbaum, E. E., Klein, R. S., & Friedland, G. H. (1993). Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Annals of Internal Medicine, 118(5), 350-355.

Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. / Gourevitch, Marc; Selwyn, Peter A.; Davenny, Katherine; Buono, Donna; Schoenbaum, Ellie E.; Klein, Robert S.; Friedland, Gerald H.

In: Annals of Internal Medicine, Vol. 118, No. 5, 01.03.1993, p. 350-355.

Research output: Contribution to journalArticle

Gourevitch, M, Selwyn, PA, Davenny, K, Buono, D, Schoenbaum, EE, Klein, RS & Friedland, GH 1993, 'Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users', Annals of Internal Medicine, vol. 118, no. 5, pp. 350-355.
Gourevitch, Marc ; Selwyn, Peter A. ; Davenny, Katherine ; Buono, Donna ; Schoenbaum, Ellie E. ; Klein, Robert S. ; Friedland, Gerald H. / Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. In: Annals of Internal Medicine. 1993 ; Vol. 118, No. 5. pp. 350-355.
@article{d6163ea7ad5e4fd789fb25384a58f01d,
title = "Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users",
abstract = "Objective: To describe the effects of human immunodeficiency virus (HIV) infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Design: Cohort study of intravenous drug users. Setting: Medical clinic in a hospital-based methadone maintenance treatment program in New York City. Patients: Fifty patients with syphilis, of whom 31 were HIV seropositive and 19 HIV seronegative. Measurements: Serologic tests for syphilis and clinical manifestations. Results: Stage of syphilis at presentation was not associated with HIV serologic status. No unusual or fulminant manifestations of early syphilis or neurosyphilis were noted among HIV-seropositive cases. Maximum nontreponemal titers were higher among HIV-seropositive (median, 1:128) than among HIV-seronegative (median, 1:32) patients with syphilis (P = 0.05); this difference was present only among patients with first-episode syphilis. All 26 evaluable, HIV-seropositive patients treated for syphilis responded appropriately, including 13 patients given standard or less-than-standard doses of penicillin. Seven of 43 patients (16{\%}) showed reversion to negative treponemal antibody assay results after treatment for syphilis; this finding was not associated with HIV infection, CD4 count, or stage of syphilis. Low nontreponemal titer was weakly associated with treponemal test reversion. Conclusions: Infection with HIV did not alter the stage at presentation, clinical course, serologic manifestations, or response to treatment of syphilis in this cohort of intravenous drug users.",
author = "Marc Gourevitch and Selwyn, {Peter A.} and Katherine Davenny and Donna Buono and Schoenbaum, {Ellie E.} and Klein, {Robert S.} and Friedland, {Gerald H.}",
year = "1993",
month = "3",
day = "1",
language = "English (US)",
volume = "118",
pages = "350--355",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "5",

}

TY - JOUR

T1 - Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users

AU - Gourevitch, Marc

AU - Selwyn, Peter A.

AU - Davenny, Katherine

AU - Buono, Donna

AU - Schoenbaum, Ellie E.

AU - Klein, Robert S.

AU - Friedland, Gerald H.

PY - 1993/3/1

Y1 - 1993/3/1

N2 - Objective: To describe the effects of human immunodeficiency virus (HIV) infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Design: Cohort study of intravenous drug users. Setting: Medical clinic in a hospital-based methadone maintenance treatment program in New York City. Patients: Fifty patients with syphilis, of whom 31 were HIV seropositive and 19 HIV seronegative. Measurements: Serologic tests for syphilis and clinical manifestations. Results: Stage of syphilis at presentation was not associated with HIV serologic status. No unusual or fulminant manifestations of early syphilis or neurosyphilis were noted among HIV-seropositive cases. Maximum nontreponemal titers were higher among HIV-seropositive (median, 1:128) than among HIV-seronegative (median, 1:32) patients with syphilis (P = 0.05); this difference was present only among patients with first-episode syphilis. All 26 evaluable, HIV-seropositive patients treated for syphilis responded appropriately, including 13 patients given standard or less-than-standard doses of penicillin. Seven of 43 patients (16%) showed reversion to negative treponemal antibody assay results after treatment for syphilis; this finding was not associated with HIV infection, CD4 count, or stage of syphilis. Low nontreponemal titer was weakly associated with treponemal test reversion. Conclusions: Infection with HIV did not alter the stage at presentation, clinical course, serologic manifestations, or response to treatment of syphilis in this cohort of intravenous drug users.

AB - Objective: To describe the effects of human immunodeficiency virus (HIV) infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Design: Cohort study of intravenous drug users. Setting: Medical clinic in a hospital-based methadone maintenance treatment program in New York City. Patients: Fifty patients with syphilis, of whom 31 were HIV seropositive and 19 HIV seronegative. Measurements: Serologic tests for syphilis and clinical manifestations. Results: Stage of syphilis at presentation was not associated with HIV serologic status. No unusual or fulminant manifestations of early syphilis or neurosyphilis were noted among HIV-seropositive cases. Maximum nontreponemal titers were higher among HIV-seropositive (median, 1:128) than among HIV-seronegative (median, 1:32) patients with syphilis (P = 0.05); this difference was present only among patients with first-episode syphilis. All 26 evaluable, HIV-seropositive patients treated for syphilis responded appropriately, including 13 patients given standard or less-than-standard doses of penicillin. Seven of 43 patients (16%) showed reversion to negative treponemal antibody assay results after treatment for syphilis; this finding was not associated with HIV infection, CD4 count, or stage of syphilis. Low nontreponemal titer was weakly associated with treponemal test reversion. Conclusions: Infection with HIV did not alter the stage at presentation, clinical course, serologic manifestations, or response to treatment of syphilis in this cohort of intravenous drug users.

UR - http://www.scopus.com/inward/record.url?scp=0027477416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027477416&partnerID=8YFLogxK

M3 - Article

C2 - 8094280

AN - SCOPUS:0027477416

VL - 118

SP - 350

EP - 355

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 5

ER -